Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 92, Issue 6, 2001, Pages 1377-1383

  Janelle, Gregory M ^a   Urdaneta, Felipe ^a   Blas, Mark L ^a   Shryock, John ^a   Tang, Yeong Shiuh ^a   Martin, Tomas D ^a   Lobato, Emilio B ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; INOTROPIC AGENT; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PLACEBO;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; ENZYME INHIBITION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; RADIOIMMUNOASSAY; RECEPTOR DOWN REGULATION;

EID: 0035019726     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200106000-00004     Document Type: Article

References (49)

1. Immediate postoperative care of cardiac surgical patients
2. Increased risk of urgent revascularization
3. Acute myocardial dysfunction and recovery: A common occurrence after coronary artery bypass
4. Acute depression of myocardial β-adrenergic receptor signaling during cardiopulmonary bypass
5. Desensitization of myocardial β-adrenergic receptors during cardiopulmonary bypass: Evidence for early uncoupling and late downregulation
6. The direct and interactive effects of phosphodiesterase inhibition and β-adrenergic stimulation on myocyte contractile function after hypothermic cardioplegic arrest
7. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts
8. Evaluation of a new bipyridine inotropic agent - Milrinone - In patients with severe congestive heart failure
9. Adenosine 3′,5′-phosphate in biological material. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine
10. Myocardial actions of milrinone: Characterization of its mechanism of action
11. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone
12. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts
13. Beneficial effect of amrinone on the size of acute regional ischemia in isolated rabbit hearts
14. Role of ischemia-reperfusion on myocardial cyclic AMP and cyclic AMP phosphodiesterase: Effects of amrinone and regional myocardial force and shortening
15. 2 or lactate and, by improving myocardial performance, preserves myocardial blood flow in the ischemic canine heart
16. Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow
17. The use of intravenous milrinone in chronic symptomatic ischemic heart disease
18. Acute positive inotropic intervention: The phosphodiesterase inhibitors
19. Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts
20. 1 adenosine receptors stably expressed in Chinese hamster ovary cells
21. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of betablockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors
22. Acute myocardial β-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease
23. Anoxia-induced release of noradrenaline from the isolated perfused heart
24. Catecholamines in myocardial ischemia: Systemic and cardiac release
25. Alterations in β-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion
26. One hour of myocardial ischemia in conscious dogs increases β-adrenergic receptors, but decreases adenylate cyclase activity
27. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man
28. Myocardial stunning and reperfusion injury in cardiac surgery
29. Uncoupling of human cardiac β-adrenoreceptors during cardiopulmonary bypass with cardioplegic cardiac arrest
30. Myocardial catecholamines following cold cardioplegic arrest during open-heart surgery
31. β-Adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass
32. Milrinone and dobutamine in severe heart failure: Differing hemodynamic effects and individual patient responsiveness
33. The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart
34. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals
35. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors
36. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass
37. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery
38. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction
39. Identification of direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure
40. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique
41. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure
42. Milrinone, dobutamine, and nitroprusside: Comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure
43. Intermittent warm blood cardioplegia preserves myocardial β-adrenergic receptor function
44. Compartmentalization of adenosine 3′:5′-monophosphate and adenosine 3′:5′-monophosphate-dependent protein kinase in heart tissue
45. Isolation and characterization of a novel cardiac adenylylcyclase cDNA
46. Functional compartmentation of cyclic AMP and protein kinase in heart
47. 2-adrenergic modulation of cardiac excitation-contraction coupling
48. Myocardial dysfunction following cardiopulmonary bypass: Recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration
49. + exchange